Is sugammadex FDA approved?
Is sugammadex FDA approved? Approximately 8 years after the initial FDA submission, sugammadex , owned and marketed by Merck, received FDA approval on December 16, 2015. Sugammadex represents a novel and new drug, which offers several important advantages over current anticholinesterase reversal agents. What is Bridion used for? BRIDION is an injection intended to reverse the effects of certain neuromuscular blocking drugs, called rocuronium bromide and vecuronium bromide, which are used during certain types of surgery in adults. Who makes bridion? For the past 7 years Merck ($MRK) has maintained a star rating by its program for Bridion (sugammadex), remaining...